<DOC>
	<DOCNO>NCT00057408</DOCNO>
	<brief_summary>This 12-week study investigates use olanzapine decrease disruptive behavior sometimes associate Autism child , age 3 12 year old . The first six week study double-blind placebo control , mean patient receive either placebo olanzapine , neither researcher patient know whether receive placebo olanzapine . In second six week patient receive olanzapine . The purpose use placebo otherwise impossible know effective drug whether drug cause side effect . Patients treat placebo improvement side effect . In study patient receive psychiatric evaluation , physical examination , laboratory test , study medication ( olanzapine placebo ) , free charge .</brief_summary>
	<brief_title>A Controlled Study Olanzapine Children With Autism</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . Males female , Aged 3 12 year . 2 . Autistic disorder DSMIV criterion . 3 . A score least moderately impaired CGISeverity item . 4 . Clinical judgment medication treatment autism indicate . 1 . Rett 's disorder , childhood disintegrative disorder , Asperger 's disorder , PDD , NOS . 2 . Psychotic disorder ( DSMIV ) ( include schizophreniform disorder schizophrenia ) . 3 . Major depressive disorder ( DSMIV ) . 4 . Bipolar disorder ( DSMIV ) . 5 . History psychoactive drug previous 2 week prior phase 1 . 6 . A history treatment olanzapine cumulative period great 2 week prior enter phase 1 . 7 . Systemic disease cardiac , renal , thyroid disease , uncontrolled seizure disorder ( seizure disorder control antiepileptic medication child seizure free period 6 month stable dose antiepileptic drug would consider control ) , diabetes mellitus . 8 . Children known medical cause autistic disorder . 9 . Abnormal fast blood glucose history diabetes . 10 . Baseline body mass index ( BMI ) great 90th percentile age gender ( CDC growth chart , Kuczmarski et al , 2000 ) ( risk weight gain ) . 11 . Baseline QTc &gt; 450 msec . Note : Historically , patient evaluate QTc value &gt; 450 . 12 . Dyskinesias baseline ( per criterion Schooler Kane , 1982 ) .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Autism</keyword>
	<keyword>Pervasive Developmental Disorder</keyword>
	<keyword>Treatment</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Antipsychotic</keyword>
</DOC>